ROCCO, Flavio
ROCCO, Flavio
SCIENZA E TECNOLOGIA DEL FARMACO
(E) and (Z)-29-methylidene-2,3-oxidosqualene as stereospecific mechanism-based inhibitors of 2,3-oxidosqualene cyclase.
1997-01-01 Ceruti M.; Rocco F.; Cattel L.
10 and 19-azasqualene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase from pig liver.
1995-01-01 Ceruti M.; Viola F.; Balliano G.; Rocco F.; Cattel L.
1H-NMR and 13C-NMR studies for the assignment of the structure of (6E)-10-azasqualene 2,3-epoxide and (6Z)-10-azasqualene 2,3-epoxide and their correlation with hypocholesterolemic and antifungal activity.
1991-01-01 Ceruti M.; Grosa G.; Rocco F.
Antifungal and cytotoxic activiti of two inhibitors of 2,3-oxidosqualene cyclase
2005-01-01 Voyron S.; Forni P.; Rocco F.; Ceruti M.; Filipello Marchisio V.
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase.
2005-01-01 Voyron S.; Forni P.; Rocco F.; Ceruti M.; Filipello Marchisio V.
Biocompatible micelles based on amphiphilic polyaspartamide-squalene derivatives as potential colloidal drug carriers.
2009-01-01 Ognibene M.C.; Rocco F.; Craparo E.F.; Picone P.; Ceruti M.; Giammona G.
Biopharmaceutical characterization of squalenoyl-cytarabine nanoparticles
2009-01-01 Rocco F.; Cosco D.; Vono M.; Paolino D.; Ceruti M.; Fresta M.
Calorimetric evidence of the interaction of a lipophilic conjugate of cytarabine with biomembrane models.
2009-01-01 Sarpietro M.G.; Micieli D.; Giuffrida M.C.; Rocco F.; Ceruti M.; Castelli F.
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici.
2000-01-01 Cattel L.; Arpicco S.; Ceruti M.; Rocco F.; Dosio F.; Brusa P.
Comparison of NMR data with molecular dynamic calculations for squalenoyl-gemcitabine and derivatives
2012-01-01 Ceruti M.; Rocco F.; Di Pietro M.E.; De Luca G.; Tocci E.
Conjugation of Acyclovir with squalene as a tool to enhance its interaction with biomembrane models: a differential scanning calorimetry study.
2008-01-01 Castelli F.; Sarpietro M.G.; Micieli D.; Rocco F.; Ceruti M.
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine
2003-01-01 B. Stella; F. Rocco; M.L. Immordino; S. Arpicco; G. Caron; F. Dosio; M. Ceruti; L. Cattel
Cytotoxic activity of a new GABA analogous.
2001-01-01 Buonerba M.; Saturnino C.; Capasso A.; Paesano N.; Barone G.; Rocco F.; Diversi E.; De Martino G.
Cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs
2004-01-01 Immordino M.L.; Brusa P.; Arpicco S.; Rocco F.; Cattel L.
Development of nonpolymeric nanoparticles for acyclovir ocular delivery
2008-01-01 B. Stella; S. Burgalassi; M. Marinari; F. Rocco; S. Arpicco; F. Dosio; L. Cattel; P. Chetoni
Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules
2006-01-01 B. Stella; S. Arpicco; F. Rocco; V. Marsaud; J.-M. Renoir; L. Cattel; P. Couvreur
Enhancenent of gemcitabine affinity for biomembrane models by conjugation with squalene
2007-01-01 F. Castelli; M.G. Sarpietro; D. Micieli; F. Rocco; B. Stella; L. Cattel
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae.
2002-01-01 Ceruti M.; Viola F.; Balliano G.; Milla P.; Rocco F.
Feniltio e metiltio dieni coniugati, inibitori delle ossidosqualene e squalene-hopene ciclasi.
2002-01-01 Ceruti M.; Arpicco S.; Rocco F.
In vitro metabolism of 7-(1,3-thiazolidin-2ylmethyl)theophylline: the metabolic fate of the 1,3-thiazolidine ring.
1990-01-01 Grosa G.; Ceruti M.; Caputo O.; Rocco F.; Biglino G.